Feb 12
The FDA is exploring innovations that could help it track drugs, including blockchain, and it has a new pilot program to test them out. The agency revealed its pilot program in an announcement today, explaining that drug manufacturers, stakeholders, repackagers, and others can test the “emerging approaches” to verifying and tracing prescription drugs in the United States. The pilot program … Continue reading
Post a Comment